[1] Tang S, Gao L, Bi Q, et al. SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma[J]. PLoS One, 2013, 8(1): e52184. [2] van Hagen P, Hulshof MCCM, van Lanschot J J B, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer[J]. N Engl J Med, 2012, 366(22): 2074-2084. [3] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. Cancer J Clin, 2013, 63(1): 11-30. [4] Hanke J H, Landolfi N F, Tucker P W, et al. Identification of murine nuclear proteins that bind to the conserved octamer sequence of the immunoglobulin promoter region[J]. Proc Natl Acad Sci USA, 1988, 85(10): 3560-3564. [5] Dong B, Horowitz D S, Kobayashi R, et al. Purification and cDNA cloning of hela cell p54nrb, a nuclear protein with two RNA recognition motifs and extensive homology to human splicing factor PSF and drosophilaNonA/Bj6[J]. Nucleic Acids Res, 1993, 21(17): 4085-4092. [6] Kuwahara S, Ikei A, Taguchi Y, et al. PSPC1, NONO, and SFPQ are expressed in mouse Sertoli cells and may function as coregulators of androgen receptor-mediated transcription[J]. Biol Reprod, 2006,75(3): 352-359. [7] Fox A H, Bond C S, Lamond A I. P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an RNA-dependent manner[J]. Mol Biol Cell, 2005,16(11): 5304-5315. [8] Kameoka S, Duque P, Konarska M M. p54(nrb) associates with the 5' splice site within large transcription/splicing complexes[J]. EMBO J,2004,23(8): 1782-1791. [9] Kaneko S, Rozenblatt-Rosen O, Meyerson M, et al. The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3' processing and transcription termination[J]. Genes Dev, 2007,21(14): 1779-1789. [10] Salton M, Lerentha Y, Wang S, et al. Involvement of Matrin 3 and sfpq/nono in the DNA damage response[J]. Cell Cycle, 2010, 9(8): 1568-1576. [11] Shav-Tal Y, Zipori D. PSF and p54nrb/NonO-multi-functional nuclear proteins[J]. FEBS Lett, 2002, 531(2): 109-114. [12] Ha K, Takeda Y, Dynan W S, et al. Sequences in PSF/SFPQ mediate radioresistance and recruitment of PSF/SFPQ-containing complexes to DNA damage sites in human cells[J]. DNA Repair: Amst, 2011, 10(3): 252-259. [13] Schiffner S, Zimara N, Schmid R, et al. P54nrb is a new regulator of progression of malignant melanoma[J]. Carcinogenesis, 2011, 32(8): 1176-1182. [14] Clark J, Lu Y J, Sidhar S K, et al. Fusion of splicing factor genes PSF and NonO/p54nrb to the TFE3 gene in papillary renal cell carcinoma[J]. Oncogene, 1997, 15(18): 2233-2239. [15] Tsofack S P, Garand C, Sereduk C, et al. NonO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines[J]. Mol Cancer, 2011, 10: 145. [16] Ishiguro H, Uemura H, Fujinami K, et al. 55 kDa nuclearmatrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor[J]. Int J Cancer, 2003, 105(1): 26-32. [17] Zhang C, Zhanga M X, Shena Y H, et al. Role of NonO-histone interaction in TNFα-suppressed prolyl-4-hydroxylase α1[J]. Biochim Biophys Acta, 2008, 1783(8): 1517-1528. [18] Yamauchi T, Nakamura N, Hiramoto M, et al. Sepantronium bromide (YM155) induces disruption of the ILF3/p54nrb complex, which is required for survivin expression[J]. Biochem Biophys Res Commun, 2012, 425(4): 711-716. [19] 曹彦坤, 李润霄,田志辉,等. 食管鳞癌单纯放化疗预后及相关因素分析[J]. 中华肿瘤防治杂志,2015,(16):1297-1302. [20] 胡倩, 姚和瑞. 长链非编码RNA与肿瘤研究现状[J]. 中华肿瘤防治杂志, 2014,21(21):1746-1750. [21] Barboro P, Rubagotti A, Orecchia P, et al. Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis[J]. Analytical Cellular Pathology,2008,30(1):13-26. [22] Hodgson M C, Astapova I, Cheng S, et al. The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists[J]. J Biol Chem,2005,280(8):6511-6519. [23] Figueroa A, Kotani H, Toda Y, Mazan-Mamczarz K, et al. Novel roles of hakai in cell proliferation and oncogenesis[J]. Mol Biol Cell, 2009,20(15):3533-3542. |